News
Radiation therapy to the pelvis can cause sexual problems for many women with cancer. These problems can be temporary or last long-term after treatment has finished. Radiation to other body parts, ...
The celebrity was sitting at a Mexican restaurant in Orlando last month when a group of women walking by glanced at him and whispered. One of them worked up the courage to ask: “Is that Alex The ...
The Canali Postural Method (CPM), a kinesiology-based exercise therapy, provides greater pain relief and improved postural alignment for individuals with non-specific low back pain compared to ...
Between identifying a therapist who aligns with your needs, navigating different therapy approaches, and affording ongoing care, the process can be discouraging. Enter: group therapy, which offers ...
“We have made broad commitments to cell therapy, and that's clear from EsoBiotec, but other things also,” Sapra said. “We have gone from autologous to building the allogeneic [and] now ...
President Trump wants to get America’s vast army of “dropout” men back into the workforce. Attention to this problem is long overdue. Nearly 7 million men in the prime of life — over a ...
How do trade wars end? To answer that, we have to first ask ourselves: how do wars end? The answer is that once begun, they are not at all easy to end. Most of the time, trade and diplomacy are ...
Stifel analysts said that Lexeo’s data showing reduced size and thickness of the heart’s left ventricle are “supportive of a drug effect” for the company’s gene therapy in Friedreich’s ataxia ...
The B.C. government announced on Monday it is ending the program that sent some patients to the U.S. for radiation therapy. The program, which began in May 2023, offered eligible patients the ...
On the heels of a recent cost-cutting drive that severed much of AmplifyBio’s R&D capacity, the Ohio-based contract manufacturing and research hybrid has hung up its hat for good. Amplify’s ...
Lexeo Therapeutics has posted updated data in Friedreich ataxia (FA) patients, linking a gene therapy to improvements on outcomes the biotech plans to use as co-primary endpoints in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results